Cargando…

Treatment Needs and Rates of Mental Health Comorbidity in Adolescent Patients With ARFID

The purpose of this paper is to provide a descriptive overview of a single-center ARFID-specific pilot clinic that sought to better understand the specific needs of patients with ARFID including rates of comorbidities, and to gain insight into treatment requirements. A retrospective cohort study was...

Descripción completa

Detalles Bibliográficos
Autores principales: Norris, Mark L., Obeid, Nicole, Santos, Alexandre, Valois, Darcie D., Isserlin, Leanna, Feder, Stephen, Spettigue, Wendy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8327955/
https://www.ncbi.nlm.nih.gov/pubmed/34349680
http://dx.doi.org/10.3389/fpsyt.2021.680298
_version_ 1783732209644994560
author Norris, Mark L.
Obeid, Nicole
Santos, Alexandre
Valois, Darcie D.
Isserlin, Leanna
Feder, Stephen
Spettigue, Wendy
author_facet Norris, Mark L.
Obeid, Nicole
Santos, Alexandre
Valois, Darcie D.
Isserlin, Leanna
Feder, Stephen
Spettigue, Wendy
author_sort Norris, Mark L.
collection PubMed
description The purpose of this paper is to provide a descriptive overview of a single-center ARFID-specific pilot clinic that sought to better understand the specific needs of patients with ARFID including rates of comorbidities, and to gain insight into treatment requirements. A retrospective cohort study was completed on patients meeting criteria for ARFID admitted to a specialized pilot clinic within a tertiary care hospital. Over an 18 month period, a total of 26 patients were assessed and had follow-up data for a 12 month period. Patients presented with heterogeneous manifestations of ARFID and high rates of comorbid mood and anxiety disorders were noted. Treatment plans were tailored to meet individual needs at assessment and over the treatment period. A multidisciplinary approach was most often administered, including a combination of individual therapy, family therapy, medical monitoring, and prescribed medications. Only 30% of patients were treated exclusively by therapists on the eating disorder team. The experiences gained from this pilot study highlight the need for specialized resources for assessment and treatment of patients with ARFID, the importance of a multidisciplinary approach to treatment, and the necessity of utilization of ARFID-specific measures for program evaluation purposes.
format Online
Article
Text
id pubmed-8327955
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-83279552021-08-03 Treatment Needs and Rates of Mental Health Comorbidity in Adolescent Patients With ARFID Norris, Mark L. Obeid, Nicole Santos, Alexandre Valois, Darcie D. Isserlin, Leanna Feder, Stephen Spettigue, Wendy Front Psychiatry Psychiatry The purpose of this paper is to provide a descriptive overview of a single-center ARFID-specific pilot clinic that sought to better understand the specific needs of patients with ARFID including rates of comorbidities, and to gain insight into treatment requirements. A retrospective cohort study was completed on patients meeting criteria for ARFID admitted to a specialized pilot clinic within a tertiary care hospital. Over an 18 month period, a total of 26 patients were assessed and had follow-up data for a 12 month period. Patients presented with heterogeneous manifestations of ARFID and high rates of comorbid mood and anxiety disorders were noted. Treatment plans were tailored to meet individual needs at assessment and over the treatment period. A multidisciplinary approach was most often administered, including a combination of individual therapy, family therapy, medical monitoring, and prescribed medications. Only 30% of patients were treated exclusively by therapists on the eating disorder team. The experiences gained from this pilot study highlight the need for specialized resources for assessment and treatment of patients with ARFID, the importance of a multidisciplinary approach to treatment, and the necessity of utilization of ARFID-specific measures for program evaluation purposes. Frontiers Media S.A. 2021-07-16 /pmc/articles/PMC8327955/ /pubmed/34349680 http://dx.doi.org/10.3389/fpsyt.2021.680298 Text en Copyright © 2021 Norris, Obeid, Santos, Valois, Isserlin, Feder and Spettigue. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Psychiatry
Norris, Mark L.
Obeid, Nicole
Santos, Alexandre
Valois, Darcie D.
Isserlin, Leanna
Feder, Stephen
Spettigue, Wendy
Treatment Needs and Rates of Mental Health Comorbidity in Adolescent Patients With ARFID
title Treatment Needs and Rates of Mental Health Comorbidity in Adolescent Patients With ARFID
title_full Treatment Needs and Rates of Mental Health Comorbidity in Adolescent Patients With ARFID
title_fullStr Treatment Needs and Rates of Mental Health Comorbidity in Adolescent Patients With ARFID
title_full_unstemmed Treatment Needs and Rates of Mental Health Comorbidity in Adolescent Patients With ARFID
title_short Treatment Needs and Rates of Mental Health Comorbidity in Adolescent Patients With ARFID
title_sort treatment needs and rates of mental health comorbidity in adolescent patients with arfid
topic Psychiatry
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8327955/
https://www.ncbi.nlm.nih.gov/pubmed/34349680
http://dx.doi.org/10.3389/fpsyt.2021.680298
work_keys_str_mv AT norrismarkl treatmentneedsandratesofmentalhealthcomorbidityinadolescentpatientswitharfid
AT obeidnicole treatmentneedsandratesofmentalhealthcomorbidityinadolescentpatientswitharfid
AT santosalexandre treatmentneedsandratesofmentalhealthcomorbidityinadolescentpatientswitharfid
AT valoisdarcied treatmentneedsandratesofmentalhealthcomorbidityinadolescentpatientswitharfid
AT isserlinleanna treatmentneedsandratesofmentalhealthcomorbidityinadolescentpatientswitharfid
AT federstephen treatmentneedsandratesofmentalhealthcomorbidityinadolescentpatientswitharfid
AT spettiguewendy treatmentneedsandratesofmentalhealthcomorbidityinadolescentpatientswitharfid